Every 10-Q that Celanese Corp Del (CE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CE filings page.
Celanese Corporation reported Q2 2026 net sales of $2,752 million, up from $2,532 million a year earlier. Net earnings attributable to Celanese were $125 million, with diluted EPS of $1.13 versus $1.80. For the first half, net sales reached $5,089 million and net earnings attributable to Celanese were $169 million.
Operating cash flow for the first six months was $285 million, while investing activities provided $366 million, helped by $493 million of proceeds from the Micromax business sale, which generated a $50 million gain. Financing uses totaled $549 million, including $621 million of long-term debt repayments. As of June 30, 2026, cash was $1,364 million and long-term debt, including current installments, carried at $12,013 million, with a $1.75 billion U.S. revolving credit facility fully available.
The company incurred $59 million of exit and shutdown costs tied mainly to closing its Lanaken, Belgium facility and expects an additional $60 million through 2027. Environmental remediation liabilities totaled $66 million, which management does not expect to be material to financial position. A quarterly dividend of $0.03 per share, totaling $3 million, was declared for payment in August 2026.
Celanese Corporation reported improved profitability for the three months ended March 31, 2026. Net sales were $2,337 million, slightly below $2,389 million a year earlier, but operating profit rose to $214 million from $165 million as mix and one‑time items helped margins.
Net earnings attributable to Celanese were $44 million, compared with a loss of $24 million, and diluted earnings per share moved to $0.40 from a loss of $0.22. Results benefited from a $50 million gain on the sale of the Micromax business and higher equity earnings, partially offset by $20 million of restructuring charges and higher interest expense of $183 million.
Operating cash flow increased to $76 million, while investing inflows of $425 million were driven by $493 million of proceeds from the Micromax divestiture. Cash and cash equivalents rose to $1,758 million and long-term debt including current installments stood at $12,599 million, reflecting a leveraged but liquid balance sheet.
Celanese Corporation (CE) reported a large GAAP loss driven by non‑cash impairments. For Q3 2025, net sales were $2,419 million and net loss was $1,353 million as Other (charges) gains, net totaled $1,491 million. Operating loss was $1,275 million. Year‑to‑date, net sales were $7,340 million with a net loss of $1,173 million.
The quarter included a goodwill impairment of about $1.0 billion in Engineered Materials, an additional $98 million linked to the Micromax® held‑for‑sale classification, and a $346 million impairment of certain trade names. Cash from operations rose to $894 million for the nine months, lifting cash to $1,440 million and shareholders’ equity to $3,954 million. The company signed an agreement on October 28, 2025 to divest its Micromax® portfolio to Element Solutions for approximately $500 million in cash, subject to adjustments and approvals. Celanese also announced plans to close its Lanaken, Belgium facility, expecting $70–$90 million of exit and shutdown costs during 2026–2028.
Debt stood at $11,655 million long‑term (net), with March 2025 note issuances of $700 million (2030, 6.500%), €750 million (2031, 5.000%) and $1,100 million (2033, 6.750%), alongside tender offers for €552 million (2026) and $500 million (2027) notes.
Celanese reported mixed second-quarter results. Net sales declined to $2,532 million from $2,651 million a year earlier, and six-month sales fell to $4,921 million from $5,262 million. Despite lower sales, net earnings attributable to Celanese were $199 million for the quarter versus $155 million in Q2 2024, with diluted EPS of $1.81 versus $1.41.
Cash and liquidity improved: cash and cash equivalents rose to $1,173 million and operating cash flow for the six months was $447 million. Long-term debt increased to $12,689 million (net of current installments) driven by new debt issuances in 2025, including the 2025 Offering. The Company completed tender offers to retire near-term notes and announced intent to divest the Micromax portfolio. Significant foreign currency translation losses and other comprehensive loss reduced AOCI to $(903) million, and accumulated goodwill impairment in Engineered Materials remains $1.5 billion.